257 related articles for article (PubMed ID: 28678584)
1. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CDK-mediated phosphorylation of Smad3 results in decreased oncogenesis in triple negative breast cancer cells.
Tarasewicz E; Rivas L; Hamdan R; Dokic D; Parimi V; Bernabe BP; Thomas A; Shea LD; Jeruss JS
Cell Cycle; 2014; 13(20):3191-201. PubMed ID: 25485498
[TBL] [Abstract][Full Text] [Related]
3. The peptidyl-prolyl isomerase PIN1 relieves cyclin-dependent kinase 2 (CDK2) inhibition by the CDK inhibitor p27.
Cheng CW; Leong KW; Ng YM; Kwong YL; Tse E
J Biol Chem; 2017 Dec; 292(52):21431-21441. PubMed ID: 29118189
[TBL] [Abstract][Full Text] [Related]
4. Impact of cyclin E overexpression on Smad3 activity in breast cancer cell lines.
Cooley A; Zelivianski S; Jeruss JS
Cell Cycle; 2010 Dec; 9(24):4900-7. PubMed ID: 21150326
[TBL] [Abstract][Full Text] [Related]
5. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
[TBL] [Abstract][Full Text] [Related]
6. Peptidyl-prolyl cis-trans isomerase NIMA interacting 1 regulates skeletal muscle fusion through structural modification of Smad3 in the linker region.
Islam R; Yoon H; Shin HR; Bae HS; Kim BS; Yoon WJ; Woo KM; Baek JH; Lee YS; Ryoo HM
J Cell Physiol; 2018 Dec; 233(12):9390-9403. PubMed ID: 30132832
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells.
Zelivianski S; Cooley A; Kall R; Jeruss JS
Mol Cancer Res; 2010 Oct; 8(10):1375-87. PubMed ID: 20736297
[TBL] [Abstract][Full Text] [Related]
8. 4-Acetylantroquinonol B induced DNA damage response signaling and apoptosis via suppressing CDK2/CDK4 expression in triple negative breast cancer cells.
Satriyo PB; Su CM; Ong JR; Huang WC; Fong IH; Lin CC; Aryandono T; Haryana SM; Deng L; Huang CC; Tzeng YM; Chao TY; Liu HW; Yeh CT
Toxicol Appl Pharmacol; 2021 Jul; 422():115493. PubMed ID: 33727089
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer.
Rao SS; Stoehr J; Dokic D; Wan L; Decker JT; Konopka K; Thomas AL; Wu J; Kaklamani VG; Shea LD; Jeruss JS
Oncotarget; 2017 Oct; 8(48):83925-83939. PubMed ID: 29137393
[TBL] [Abstract][Full Text] [Related]
10. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
11. Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins.
Nakano A; Koinuma D; Miyazawa K; Uchida T; Saitoh M; Kawabata M; Hanai J; Akiyama H; Abe M; Miyazono K; Matsumoto T; Imamura T
J Biol Chem; 2009 Mar; 284(10):6109-15. PubMed ID: 19122240
[TBL] [Abstract][Full Text] [Related]
12. Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex.
Aoyama S; Kido Y; Kanamoto M; Naito M; Nakanishi M; Kanna M; Yamamotoya T; Asano T; Nakatsu Y
Exp Cell Res; 2023 Apr; 425(2):113544. PubMed ID: 36906101
[TBL] [Abstract][Full Text] [Related]
13. CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin.
Tarasewicz E; Hamdan R; Straehla J; Hardy A; Nunez O; Zelivianski S; Dokic D; Jeruss JS
Cancer Biol Ther; 2014 Oct; 15(10):1301-11. PubMed ID: 25006666
[TBL] [Abstract][Full Text] [Related]
14. Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.
Huang CC; Huang MS; Chung HJ; Chiu SY; Yadav P; Lin Y; Liu F; Matsuura I
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3664-3671. PubMed ID: 30251686
[TBL] [Abstract][Full Text] [Related]
15. Embryonic stem cell secreted factors decrease invasiveness of triple-negative breast cancer cells through regulome modulation.
Tarasewicz E; Oakes RS; Aviles MO; Straehla J; Chilton KM; Decker JT; Wu J; Shea LD; Jeruss JS
Cancer Biol Ther; 2018 Apr; 19(4):271-281. PubMed ID: 29053396
[TBL] [Abstract][Full Text] [Related]
16. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
[TBL] [Abstract][Full Text] [Related]
17. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 Gains Its Function via c-Myc Activation upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding.
Liao P; Zeng SX; Zhou X; Chen T; Zhou F; Cao B; Jung JH; Del Sal G; Luo S; Lu H
Mol Cell; 2017 Dec; 68(6):1134-1146.e6. PubMed ID: 29225033
[TBL] [Abstract][Full Text] [Related]
19. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
20. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
